Askim, Sweden

Margareta Nordlander

This inventor holds 2 USPTO granted patents. Top assignee: Astra Aktiebolag. Active years: 1998-1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Margareta Nordlander. Retrieved from https://idiyas.com/inventor/margareta-nordlander

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.7

ph-index = 2

Forward Citations = 50(Granted Patents)


Company Filing History:


Years Active: 1998-1999

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Margareta Nordlander: Innovator in Pharmaceutical Science

Introduction

Margareta Nordlander is a prominent inventor based in Askim, Sweden. She has made significant contributions to the field of pharmaceutical science, particularly in the development of innovative drug formulations. With a total of 2 patents to her name, her work has had a notable impact on the industry.

Latest Patents

Among her latest patents are advancements in short-acting dihydropyridines and a novel pharmaceutical emulsion. These inventions reflect her commitment to improving drug efficacy and patient outcomes.

Career Highlights

Margareta currently works at Astra Aktiebolag, a leading pharmaceutical company known for its research and development in innovative medicines. Her role at Astra has allowed her to further her research and contribute to groundbreaking projects in the pharmaceutical sector.

Collaborations

Throughout her career, Margareta has collaborated with esteemed colleagues such as Kjell Hjalmar Andersson and Rolf Christer Westerlund. These partnerships have fostered a collaborative environment that enhances the innovation process.

Conclusion

Margareta Nordlander exemplifies the spirit of innovation in the pharmaceutical industry. Her contributions through her patents and collaborations continue to shape the future of medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…